KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Change in Acquisitions & Divestments (2021 - 2025)

Historic Change in Acquisitions & Divestments for AbCellera Biologics (ABCL) over the last 5 years, with Q3 2025 value amounting to $83.1 million.

  • AbCellera Biologics' Change in Acquisitions & Divestments fell 5773.28% to $83.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $588.4 million, marking a year-over-year decrease of 4139.23%. This contributed to the annual value of $937.9 million for FY2024, which is 295.79% up from last year.
  • According to the latest figures from Q3 2025, AbCellera Biologics' Change in Acquisitions & Divestments is $83.1 million, which was down 5773.28% from $113.4 million recorded in Q2 2025.
  • AbCellera Biologics' 5-year Change in Acquisitions & Divestments high stood at $306.5 million for Q1 2024, and its period low was $18.1 million during Q4 2021.
  • In the last 5 years, AbCellera Biologics' Change in Acquisitions & Divestments had a median value of $193.3 million in 2024 and averaged $172.8 million.
  • In the last 5 years, AbCellera Biologics' Change in Acquisitions & Divestments skyrocketed by 41099.5% in 2022 and then tumbled by 5773.28% in 2025.
  • AbCellera Biologics' Change in Acquisitions & Divestments (Quarter) stood at $18.1 million in 2021, then soared by 410.99% to $92.4 million in 2022, then soared by 190.09% to $268.0 million in 2023, then decreased by 24.67% to $201.9 million in 2024, then crashed by 58.84% to $83.1 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $83.1 million for Q3 2025, versus $113.4 million for Q2 2025 and $190.0 million for Q1 2025.